Meeting
2023 ASCO Annual Meeting
Treatments and outcomes of patients with localized extranodal NK/T-cell lymphoma (ENKL) diagnosed between 2014 and 2021: A cooperative study in Japan.
Authors
Kana Miyazaki
Mie University Graduate School of Medicine, Tsu, Japan
Kana Miyazaki , Ayumi Fujimoto , Senzo Taguchi , Naoko Asano , Wataru Munakata , Mitsuhito Hirano , Masahiro Takeuchi , Jun Amaki , Jun Takizawa , Noriko Fukuhara , Rika Sakai , Takeshi Maeda , Toshiyuki Imagumbai , Yuri Miyazawa , Yoshihiro Kameoka , Makoto Yoshimitsu , Isao Tawara , Yasuo Ejima , Ritsuro Suzuki , Motoko Yamaguchi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Track
Hematologic Malignancies
Sub Track
Non-Hodgkin Lymphoma
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 7565)
DOI
10.1200/JCO.2023.41.16_suppl.7565
Abstract #
7565
Poster Bd #
116
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Outcomes and prognostic factors of radiotherapy with dexamethasone, etoposide, ifosfamide, and carboplatin (RT-DeVIC) for newly diagnosed, localized extranodal NK/T-cell lymphoma, nasal type (ENKL): a cooperative study in Japan.
First Author: Motoko Yamaguchi
Poster
2016 ASCO Annual Meeting
Prognostic value of tumor response in pediatric and adult patients with Ewing sarcoma.
First Author: Melanie Ann Chihak
Poster
2015 Genitourinary Cancers Symposium
Risk-stratified treatment of patients with metastatic germ cell tumor with progression after first-line therapy.
First Author: Orvar Gunnarsson
Poster
2014 Gastrointestinal Cancers Symposium
Effectiveness study of gemcitabine, oxaliplatin, and capecitabine as first-line treatment for nonresectable biliary tract cancer.
First Author: Lars Henrik Jensen